Kangmingna is committed to creating a high-end medical device "smart" manufacturing highland - Dialogue with Long Shushan, General Manager of Anqing Kangmingna Packaging Co., Ltd. and Chairman of Anhui Madpus Medical Technology Co., Ltd

On March 27th, during the "Yiqi" Dialogue with Entrepreneurs, we walked into the Yixiu Economic Development Zone to watch a conversation between the reporter and Long Shushan, the President of the Anqing Women Entrepreneurs Association, the Chairman of Anhui Madpus Medical Technology Co., Ltd., and the General Manager of Anqing Kangmingna Packaging Co., Ltd.Long Shushan is in charge of two enterprises, Anhui Madpus Medical Technology Co., Ltd. and Anqing Kangmingna Packaging Co., Ltd., to build a medical full industry chain ecosystem driven by dual core technology. Medplus Medical is committed to building a high-end medical device intelligent manufacturing highland, with products exported to more than 80 countries around the world; Kangmingna Packaging Innovation breaks through the technological barriers of medical sterilization packaging and becomes the largest sterilization consumables base in Asia.

Host Fang Ying

After this year's Spring Festival 'Top 100' promotion conference, I see that many companies in Anqing have also put in a lot of effort and doubled their confidence. As a benchmark enterprise in Anqing's medical technology field, what are your thoughts on how to integrate into the overall work of 'Top 100' promotion

Long Shushan, Chairman of Anhui Medplus Medical Technology Co., Ltd. and General Manager of Anqing Kangmingna Packaging Co., Ltd

A strong enterprise leads to a strong city. We will inject surging momentum into Anqing's entry into the top 100 with the spirit of 'how many opportunities can one have in life'. In the journey of 'striving for the top 100', enterprises are not only participants, but also the main force. Medplus and Kangmingna take technological innovation as the fulcrum to promote the coordinated development of the industrial chain. We will actively integrate into the strategy of 'building internal platforms and reaching out to fellow villagers', deepen industry university research cooperation, accelerate technological transformation, and rely on platforms such as the Yishang Conference and academician expert symposiums to link more resources and promote the development of the industrial chain

Host Fang Ying

Now we have arrived at the production workshop of our company's surgical gowns, right? I think the products produced on both sides are disposable surgical gowns that surgeons need to use

Long Shushan, Chairman of Anhui Medplus Medical Technology Co., Ltd. and General Manager of Anqing Kangmingna Packaging Co., Ltd

This product is made of our medical non-woven fabric material. Currently, our main export directions for this order are Saudi Arabia and South America. We are currently producing a three-year Saudi Arabian label, which is exported to Saudi Arabia (government). (Is there no need to worry about sales anymore?) Yes. (So how much does it produce in a year?) Our daily production capacity is about 10000 pieces. (More than 10000 pieces per day, which is more than 3 million pieces per year.) Yes. Medpus Medical and Kangmingna Packaging are medical technology companies rooted in Anqing and radiating globally. As a national high-tech enterprise, Medplus focuses on the research and development of disposable medical non-woven fabric products, high-end hemostatic materials, and medical disinfection products, breaking the monopoly of international giants. Its products cover general surgery, minimally invasive surgery, and other fields, and are exported to more than 80 countries such as Europe, America, and Southeast Asia. The company has 12 national invention patents, led the drafting of one industry standard, and achieved international advanced level in hemostatic microsphere technology. In 2024, the sales revenue exceeded 30 million US dollars. As a leading enterprise in sterilization packaging in China, Kangmingna has a global market share of 30%. Its products have passed international certifications such as the US FDA and the EU CE. The company has 3 major production bases and 63 patents. By 2024, the output value will reach 300 million yuan, firmly ranking first in the domestic industry

Host Fang Ying

Mr. Long, we just walked around the exhibition hall and found that in addition to various honors and medals that our company has won, the hall is also filled with various products produced by our company. If you were to recommend the most competitive product of our company, which one would you recommend

Long Shushan, Chairman of Anhui Medplus Medical Technology Co., Ltd. and General Manager of Anqing Kangmingna Packaging Co., Ltd

If I were to recommend it, it would be the absorbable hemostatic microspheres that we are currently applying for the National Medical Device Class III Certificate for. (This is such a small device, isn't it? What is its function?) This product is mainly used in our surgical, general surgery, cardiovascular, and cosmetic departments for clinical surgical venous hemostasis. (How is the application situation in this market?) We will start to layout our overseas markets in 2022, and make its debut in Dubai, Germany, and Brazil. (Many products are exported, right?) Yes

Host Fang Ying

We say that technological innovation is the foundation of a company's existence, so what are the unique features of our company in terms of technological innovation

Long Shushan, Chairman of Anhui Medplus Medical Technology Co., Ltd. and General Manager of Anqing Kangmingna Packaging Co., Ltd

"It has always been a tenet of our company to lead the future through scientific and technological innovation. At present, we are working with the University of the Chinese Academy of Sciences, the Beijing Institute of Mechanical Industry Automation, as well as the University of Science and Technology of China and Jiangnan University. After years of cooperation and development, we have conquered four core technologies, including polyvinyl alcohol hemostatic sponge, which has conquered our" choke "technology and realized the blank of domestic products

Host Fang Ying

How does our company plan its layout in 2025 by anchoring the goal of entering the top 100 cities

Long Shushan, Chairman of Anhui Medplus Medical Technology Co., Ltd. and General Manager of Anqing Kangmingna Packaging Co., Ltd

"In 2025, we will have two plans and one action capacity doubling plan. Cuminer will invest 120 million yuan to expand a new 50 mu factory area. Our sterile packaging production lines will reach 4.5 million per day, and Medepos will start our Phase II intelligent workshop to open our sterile production lines across the line. The second is our global partnership plan. We will deepen the layout of the" the Belt and Road ", establish a European research and development center, overseas warehouse and European pharmaceutical enterprises to jointly build a joint laboratory to tackle technical challenges. We will continue to build a joint research and development center with our Wenzhou Research Institute to study our biodegradable hemostatic materials, seize a new highland of our regenerative medicine, and" rush "for Anqing The goal of" Top 100 "contributes to the strength of our enterprise."